SCHEMBL6537493

SCHEMBL6537493

O=c1cc[nH]c2c([N+](=O)[O-])cccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.58
▸ PARP1 P09874 1/20 0.53
▸ DNA2 P51530 1/20 0.52
▸ CASP6 P55212 1/20 0.52
▸ CTDSP1 Q9GZU7 1/20 0.52
▸ TDP1 Q9NUW8 4/20 0.52
▸ CCR8 P51685 1/20 0.52
▸ KMT2A Q03164 3/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ HSD17B10 Q99714 2/20 0.50
▸ MAPT P10636 3/20 0.49
▸ NPC1 O15118 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ DYRK1A Q13627 1/20 0.43
▸ CLK1 P49759 1/20 0.43
▸ GSK3B P49841 1/20 0.43
▸ CDK5 Q00535 1/20 0.43
▸ CDK5R1 Q15078 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8604489 0.81 ALDH1A1 (0.53) ALDH1A1PARP1DNA2CASP6CTDSP1
SCHEMBL6537755 0.77 CHUK (0.48) ALDH1A1CCR8KMT2AMAPTNPC1
SCHEMBL259909 0.77 TDP1 (0.54) ALDH1A1PARP1DNA2CASP6CTDSP1
SCHEMBL30275708 0.76 DNA2 (0.56) ALDH1A1PARP1DNA2CASP6CTDSP1
SCHEMBL1017079 0.76 DNA2 (0.56) ALDH1A1PARP1DNA2CASP6CTDSP1
SCHEMBL6538378 0.76 DNA2 (0.63) ALDH1A1PARP1DNA2CASP6CTDSP1
SCHEMBL6537634 0.76 GRIN2D (0.49) ALDH1A1TDP1CCR8KMT2AKDM4E
SCHEMBL6538005 0.76 CCR8 (0.43) ALDH1A1DNA2CASP6CTDSP1TDP1
SCHEMBL11003986 0.74 TDP1 (0.48) ALDH1A1DNA2CASP6CTDSP1TDP1
SCHEMBL30799237 0.74 TDP1 (0.48) ALDH1A1DNA2CASP6CTDSP1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 — — EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 — — US disclosed
EP-0876345-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-11-11 — — EP disclosed
WO-1997014681-A1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-04-24 — — WO disclosed
Send feedback